Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro

Published:2000-02-24 Issue:5 Volume:7 Page:408-416
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Klebba C,Ottmann O G,Scherr M,Pape M,Engels J W,Grez M,Hoelzer D,Klein S A

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301094.pdf

Reference24 articles.

1. Sarver N et al. Ribozymes as potential anti-HIV-1 therapeutic agents Science 1990 247: 1222–1225

2. Ojwang JO et al. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme Proc Natl Acad Sci USA 1992 89: 10802–10806

3. Rossi JJ, Sarver N . RNA enzymes (ribozymes) as antiviral therapeutic agents Trends Biotechnol 1990 8: 179–183

4. Gervaix A et al. Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals Hum Gene Ther 1997 8: 2229–2238

5. Li X et al. Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies Gene Therapy 1998 5: 233–239

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Technology Therapy Using Biomolecules or Synthetic Compounds for HIV Inhibition;Nanomedicine for Drug Delivery and Therapeutics;2013-01-30

2. In VivoSelection of CD4+T Cells Transduced with a Gamma-Retroviral Vector Expressing a Single-Chain Intrabody Targeting HIV-1 Tat;Human Gene Therapy;2012-09

3. Identification and Characterization of a Highly Efficient Anti-HIV Pol Hammerhead Ribozyme;Oligonucleotides;2009-09

4. Ribozyme- and Deoxyribozyme-Strategies for Medical Applications;Current Drug Targets;2004-11-01

5. Three Properties of the Hepatitis C Virus RNA Genome Related to Antiviral Strategies Based on RNA-Therapeutics: Variability, Structural Conformation and tRNA Mimicry;Current Pharmaceutical Design;2004-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3